chapter 44- Pharm of hematopoiesis and immunomodulation Flashcards
what is the clinical application of oprelvekin
prevention of severe chemotherapy-induced thrombocytopenia
what are the contraindications for erythropoietin/ darbepoetin
uncontrolled HTN and hypertensive encephalopathy
how does oprelvekin differ from IL-11
lack of N-terminal proline residue
how does sargramostin effect eosinophil levels
mild and dose-dependent increase in eosinophils
what are some side effects of oprelvekin
fluid retention, atrial fibrillation, oral candidiasis, conjunctival hyperemia; fatigue
what is romiplostim
recombinant IgG1 Fc-peptide fusion protein the binds and activates the TPO receptor
how is romiplostim administered
subcutaneous injection once weekly
what does oprelvekin cause dose-dependent increase in
platelet count and in number of megakaryocytic in bone marrow
what are some side effects of hydroxyurea
myelosuppression, skin ulcer, secondary leukemia with long-term use
what is the clinical application of romiplostim
idiopathic thrombocytopenia purport unresponsive to corticosteroids, immunoglobulins, or splenectomy
what is the clinical application of erythropoietin and darbepoetin
cancer-associated and chemotherapy-induced anemia; anemia of chronic kidney disease
what drug involved in hematopoiesis and immunomodulation may be abused by athletes
erythropoietin / darbepoetin
what is the clinical application of sargramostim
neutropenia, peripheral-blood stem cell harvest
what can happen if epoetin or darbepoetin are administered to non anemia or mildly anemic patients
polycythemia, blood hyper viscosity, and stroke or MI
how do you administered erythropoietin
parenterally